Artificial intelligence (AI) is already being utilized by 40% to 50% of practices, with projections of 70% to 80% adoption in the next few years. After presenting on the future implications of AI in oncology at the 2025 Community Oncology Conference, organized by the Community Oncology Alliance (COA), in Orlando, Florida, Nini Wu, MD, MBA, chief medical and development officer at Navista, Cardinal Health, discussed the rapid integration of AI in oncology.
AI enhances patient care by…
Article Source
https://www.ajmc.com/view/nini-wu-md-on-the-future-implications-of-ai-in-oncology-from-revenue-to-patient-support
